...
首页> 外文期刊>International journal of laboratory hematology >Management of patients receiving oral anticoagulants using computer dosing software--does everyone agree? Data from a UK NEQAS (blood coagulation) exercise.
【24h】

Management of patients receiving oral anticoagulants using computer dosing software--does everyone agree? Data from a UK NEQAS (blood coagulation) exercise.

机译:使用计算机剂量软件管理接受口服抗凝剂的患者-每个人都同意吗?来自英国NEQAS(血液凝结)练习的数据。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

INTRODUCTION: The quality of anticoagulation management is not readily or frequently assessed, particularly between different centres. This study sought to evaluate agreement in oral anticoagulant management decisions between participating centres in UK NEQAS programmes. METHODS: Participants were asked to indicate whether they used computerized dosing support software (CDSS) and to complete a series of questions with respect to anticoagulant management provision. Four clinical scenarios were provided, together with past and current International Normalised Ratio (INR) results. Participants were asked to provide recommendations on the target INR they would assign to the patient, the dose of warfarin and a recall interval. RESULTS: Seven hundred and fifty-nine centres returned results, of which 28% were enrolled in the hospital-based EQA programme, and 72% were participants in the point-of-care testing programme. Six hundred (79%) reported use of CDSS. In one straightforward scenario, there was 99% agreement in dose recommendation. However, for three more complex scenarios, differences were apparent in target INRs employed and both dose and recall recommendations. In some cases, differences related to the software system employed. CONCLUSION: The study emphasizes large variation in the approach to managing these scenarios and warrants further investigation, together with education including promoting national guidelines for the assignment of target ranges.
机译:简介:抗凝治疗的质量尚不容易或经常评估,尤其是在不同中心之间。这项研究旨在评估英国NEQAS计划的参与中心之间在口服抗凝剂管理决策中的一致性。方法:要求参与者指出他们是否使用计算机剂量支持软件(CDSS),并就抗凝剂管理规定完成一系列问题。提供了四种临床方案,以及过去和当前的国际标准化比率(INR)结果。要求参与者提供有关他们将分配给患者的目标INR,华法林剂量和召回间隔的建议。结果:759个中心返回了结果,其中28%的患者参加了基于医院的EQA计划,而72%的患者参加了即时检验程序。六百(79%)个报告使用CDSS。在一种简单的情况下,推荐剂量达到99%。但是,对于三种更复杂的情况,采用的目标INR以及剂量和召回建议均存在明显差异。在某些情况下,差异与所使用的软件系统有关。结论:该研究强调了应对这些情况的方法的巨大差异,需要进行进一步的调查,并进行教育,包括推广有关目标范围分配的国家指南。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号